Sensei Biotherapeutics Inc SNSE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/20/24 EDT
1.64quote price arrow up+0.14 (+9.33%)
Volume
191
Close
1.50UNCH (UNCH)
Volume
71,763
52 week range
0.51 - 1.94
Loading...
  • Open1.57
  • Day High1.64
  • Day Low1.48
  • Prev Close1.53
  • 52 Week High1.94
  • 52 Week High Date05/09/24
  • 52 Week Low0.51
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap37.621M
  • Shares Out25.08M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change116.76

KEY STATS

  • Open1.57
  • Day High1.64
  • Day Low1.48
  • Prev Close1.53
  • 52 Week High1.94
  • 52 Week High Date05/09/24
  • 52 Week Low0.51
  • 52 Week Low Date10/31/23
  • Market Cap37.621M
  • Shares Out25.08M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change116.76

RATIOS/PROFITABILITY

  • EPS (TTM)-1.20
  • P/E (TTM)-1.25
  • Fwd P/E (NTM)-1.42
  • EBITDA (TTM)-33.433M
  • ROE (TTM)-41.63%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)2.47%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sensei Biotherapeutics Inc

 

Profile

MORE
Sensei Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which is focused on the discovery and development of therapeutics for cancer patients. Through its Tumor Microenvironment Activated biologics (TMAb) platform, the Company develops conditionally active therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment to unleash T cells against tumors. Its lead investigational...
William Ringo
Independent Chairman of the Board
John Celebi
President, Chief Executive Officer, Director
Address
1405 Research Blvd, Suite 125
Rockville, MD
20850
United States

Top Peers

SYMBOLLASTCHG%CHG
ACHL
Achilles Therapeutics PLC
0.93UNCHUNCH
EYEN
Eyenovia Inc
0.74UNCHUNCH
IINN
Inspira Technologies Oxy BHN Ltd
2.18UNCHUNCH
RNXT
RenovoRx Inc
1.40UNCHUNCH
EFTR
eFFECTOR Therapeutics Inc
1.87UNCHUNCH